Regencell Bioscience Holdings Limited Operating Lease Right-of-Use Assets
Regencell Bioscience Holdings Limited (RGC) had Operating Lease Right-of-Use Assets of $544.38 thousand as of 2025-06-30, per its 20-F filed 2025-10-31.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2025-10-31
- 2025-06-30: Operating Lease, Right-of-Use Asset $544.38K.
- 2024-06-30: Operating Lease, Right-of-Use Asset $84.78K.
- 2023-06-30: Operating Lease, Right-of-Use Asset $451.08K.
- 2022-06-30: Operating Lease, Right-of-Use Asset $747.43K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-06-30 | $544.38K 20-F · filed 2025-10-31 |
| 2024-06-30 | $84.78K 20-F · filed 2025-10-31 |
| 2023-06-30 | $451.08K 20-F · filed 2024-10-25 |
| 2022-06-30 | $747.43K 20-F · filed 2023-10-27 |